Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -5.22% is 85% above its 5-year average of -35.92%, near the high end of its 5-year range (-265.39%–4.94%).
As of the fiscal period ended Tuesday, June 30, 2026. 54.23% above its 12-month average of -11.40%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -5.22%.
RETURN ON INVESTED CAPITAL (ROIC)
-5.22%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-11.40%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-18.00%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-35.92%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-40.29%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+54.23%
CURRENT VS 3Y AVG
+71.01%
CURRENT VS 5Y AVG
+85.48%
CURRENT VS 10Y AVG
+87.05%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-28.79%
median of 492 covered companies
CURRENT VS SECTOR MEDIAN
+81.88%
vs the sector median at left
Journey Medical Corporation
Market Cap
$184.12M
Return on Invested Capital (ROIC)
-5.22%
TTM Avg
-11.40%
3Y Avg
-18.00%
5Y Avg
-35.92%
Market Cap
$179.70M
Return on Invested Capital (ROIC)
-9.57%
TTM Avg
-477.38%
3Y Avg
-295.61%
5Y Avg
-295.61%
Market Cap
$176.96M
Return on Invested Capital (ROIC)
-1039.56%
TTM Avg
-137.05%
3Y Avg
-111.74%
5Y Avg
-93.55%
Market Cap
$192.97M
Return on Invested Capital (ROIC)
-74.02%
TTM Avg
-48.91%
3Y Avg
-62.69%
5Y Avg
-47.07%
Market Cap
$174.17M
Return on Invested Capital (ROIC)
-30.23%
TTM Avg
-28.70%
3Y Avg
-31.34%
5Y Avg
-41.69%
Market Cap
$173.04M
Return on Invested Capital (ROIC)
-135.38%
TTM Avg
-110.80%
3Y Avg
-91.23%
5Y Avg
-65.73%
Market Cap
$172.99M
Return on Invested Capital (ROIC)
-46.59%
TTM Avg
-39.23%
3Y Avg
-33.74%
5Y Avg
-53.74%
Market Cap
$202.05M
Return on Invested Capital (ROIC)
-51.01%
TTM Avg
-69.12%
3Y Avg
-59.60%
5Y Avg
-89.29%
Market Cap
$162.82M
Return on Invested Capital (ROIC)
-56.53%
TTM Avg
-185.89%
3Y Avg
-125.01%
5Y Avg
-88.85%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Journey Medical Corporation (DERM) | $184.12M | -5.22% | -11.40% | -18.00% | -35.92% |
| Canton Strategic Holdings Inc (CNTN)vs › | $179.70M | -9.57% | -477.38% | -295.61% | -295.61% |
| Cue Biopharma, Inc. (CUE)vs › | $176.96M | -1039.56% | -137.05% | -111.74% | -93.55% |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $192.97M | -74.02% | -48.91% | -62.69% | -47.07% |
| Precision BioSciences, Inc. (DTIL)vs › | $174.17M | -30.23% | -28.70% | -31.34% | -41.69% |
| Coherus Oncology, Inc. (CHRS)vs › | $173.04M | -135.38% | -110.80% | -91.23% | -65.73% |
| Compass Therapeutics, Inc. (CMPX)vs › | $172.99M | -46.59% | -39.23% | -33.74% | -53.74% |
| AN2 Therapeutics, Inc. (ANTX)vs › | $202.05M | -51.01% | -69.12% | -59.60% | -89.29% |
| ALX Oncology Holdings Inc. (ALXO)vs › | $162.82M | -56.53% | -185.89% | -125.01% | -88.85% |
| Electra Therapeutics Inc. (ETRA)vs › | $206.61M | N/A | N/A | N/A | N/A |
ROIC
-5.2%
ROE
-19.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -5.22% |
| 2026-03-31 | -11.28% |
| 2025-12-31 | -14.30% |
| 2025-09-30 | -10.75% |
| 2025-06-30 | -15.44% |
| 2025-03-31 | -14.83% |
| 2024-12-31 | -29.93% |
| 2024-09-30 | -56.37% |
| 2024-06-30 | 4.94% |
| 2024-03-31 | -8.49% |
| 2023-12-31 | -5.46% |
| 2023-09-30 | -48.82% |
| 2023-06-30 | -265.39% |
| 2023-03-31 | -105.95% |
| 2022-12-31 | -66.67% |
| 2022-09-30 | -51.54% |
| 2022-06-30 | -53.07% |
| 2022-03-31 | -58.17% |
| 2021-12-31 | -68.39% |
| 2021-09-30 | -65.87% |
| 2021-06-30 | -32.89% |
| 2020-12-31 | 16.99% |
| 2019-09-30 | -53.60% |
| 2019-06-30 | -53.63% |
| 2019-03-31 | -54.44% |
| 2018-12-31 | -69.98% |
| 2018-09-30 | -58.74% |
| 2018-06-30 | -78.69% |
| 2018-03-31 | -80.03% |
| 2017-12-31 | -65.28% |
| 2017-09-30 | -47.92% |
| 2017-06-30 | -15.08% |
| 2017-03-31 | -21.17% |
| 2016-12-31 | -32.29% |
| 2016-09-30 | -40.54% |
| 2016-06-30 | -37.33% |
| 2016-03-31 | -63.85% |
| 2015-12-31 | -47.75% |
| 2015-09-30 | -16.35% |
